Skip to main content
Premium Trial:

Request an Annual Quote

Jeff Whitmore, Andre Marion

Premium
Jeff Whitmore has joined Alpha Innotech as vice president of global sales, the company said. He was previously director of European life science sales for Molecular Devices. Alpha develops and manufactures digital imaging and analysis systems for the life science and drug discovery markets.
 

 
Andre Marion, a founder of Applied Biosystems, has been appointed to the board of Singulex, the company said this week. Marion served as CEO of ABI from 1986 to 1993 and was chairman of its board from 1987 to 1993. After the company merged with Perkin-Elmer, he stayed on as vice president of PE and president of ABI until 1995. The current PerkinElmer is a different company from the Perkin-Elmer of which ABI was part. That company changed its name to Applera in 2000.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.